Research Use Only
This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Overview
Experimental protocol based on the exercise mimetic SLU-PP-332 (ERRα/β/γ agonist) for enhancing fat oxidation, increasing endurance, and improving metabolic profile. For preclinical research only.
Peptides Involved
Compare the peptides included in this protocol side by side.
| Typical Dose | |||||
|---|---|---|---|---|---|
| SLU-PP-332 | Experimental | 🏋️Weight Loss | 290.32 Da | — |
Comparing 1 peptide
Dosage Schedule
SLU-PP-332: 50 mg/kg body weight (preclinical mouse doses)
Twice daily, intraperitoneally (in preclinical models)
Cycle Information
Preclinical protocol: 28 days of continuous administration. For ob/ob mice, duration was shortened to 12 days due to tolerability issues. Human cycling has not been established.
Stacking Notes
In studies, SLU-PP-332 was used as monotherapy. Potential combination with a low-calorie diet and moderate aerobic exercise may enhance the metabolic effect. Combination with GLP-1 agonists (semaglutide, tirzepatide) has not been studied.
Warnings & Precautions
FOR RESEARCH PURPOSES ONLY. Not approved for human use. All data from mouse experiments. Human dosages not established. Long-term safety not studied. WADA may classify as a prohibited substance (category S4). Not recommended for athletes.
Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.